Patients taking aspirin for secondary prevention
in studies one, two, and three had relative risk reductions in colorectal cancer of 40%, 38%, and 39%, respectively, compared with non-aspirin-using controls.
5mg) for the secondary prevention
of stroke and acute cardiac events, including myocardial infarction (heart attack).
However, the overall risk of stroke for those receiving hormone therapy for both primary and secondary prevention
was 24% higher than that of women receiving placebo treatment (relative risk, 1.
Three findings were of particular importance: prescribing of secondary prevention
medication at discharge was high (70.
This follows a review of new and emerging evidence that was felt likely to impact on the original recommendations in a number of clinical areas, including the use of statins both to lower the risk of developing cardiovascular disease and in secondary prevention
in people with established cardiovascular disease.
Not all clinicians agree; in commenting on the study, Jolatna Siller-Matula, MD, says that "The net benefit of aspirin for secondary prevention
would substantially exceed the bleeding hazard.
The study, titled"Efficacy of Omega-3 Fatty Acid Supplements (Eicosapentaenoic Acid and Docosahexaenoic Acid) in the Secondary Prevention
of Cardiovascular Disease" suggested there is insufficient evidence to prove that omega 3 fatty acid supplements offer secondary prevention
of cardiovascular events in patients with heart disease.
LEVELS VERSUS TIERS; PRIMARY VERSUS SECONDARY PREVENTION
Even in well-developed health care systems, many patients are not receiving the best secondary prevention
treatment, despite a wealth of preventative guidelines, continuing medical education and revalidation programs," said Anthony Heagerty of the University of Manchester in an accompanying editorial.
Participants of the event will visit various organizations that are engaged in secondary prevention
of HIV/AIDS and drug use, as well as working with injecting drug users, reported NGO "Property of the Republic".
This approach is established for the secondary prevention
of recurrent vascular events.
For the secondary prevention
interventions, primarily in the nature of screening, the primary responsibility resides with the providers.